EMA has published the final revised guideline (revision 3) on the evaluation of human medicines for the treatment of bacterial infections.
The revised document reflects the outcome of discussions, and also includes:
- clarifications on recommended clinical development programmes for antimicrobials intended to address an unmet need;
- guidance on clinical trials to support …
